596 related articles for article (PubMed ID: 11158001)
1. Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.
Leder BZ; Smith MR; Fallon MA; Lee ML; Finkelstein JS
J Clin Endocrinol Metab; 2001 Feb; 86(2):511-6. PubMed ID: 11158001
[TBL] [Abstract][Full Text] [Related]
2. Effects of selective testosterone and estradiol withdrawal on skeletal sensitivity to parathyroid hormone in men.
Lee H; Finkelstein JS; Miller M; Comeaux SJ; Cohen RI; Leder BZ
J Clin Endocrinol Metab; 2006 Mar; 91(3):1069-75. PubMed ID: 16352679
[TBL] [Abstract][Full Text] [Related]
3. The effect of micronized estradiol on bone turnover and calciotropic hormones in older men receiving hormonal suppression therapy for prostate cancer.
Taxel P; Fall PM; Albertsen PC; Dowsett RD; Trahiotis M; Zimmerman J; Ohannessian C; Raisz LG
J Clin Endocrinol Metab; 2002 Nov; 87(11):4907-13. PubMed ID: 12414849
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
[TBL] [Abstract][Full Text] [Related]
5. Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women.
Cosman F; Nieves J; Woelfert L; Shen V; Lindsay R
J Bone Miner Res; 1998 Jun; 13(6):1051-5. PubMed ID: 9626638
[TBL] [Abstract][Full Text] [Related]
6. A phase 3, double-blind, randomised, parallel-group, placebo-controlled study of oral weekly alendronate for the prevention of androgen deprivation bone loss in nonmetastatic prostate cancer: the Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) study.
Klotz LH; McNeill IY; Kebabdjian M; Zhang L; Chin JL;
Eur Urol; 2013 May; 63(5):927-35. PubMed ID: 23040208
[TBL] [Abstract][Full Text] [Related]
7. Effects of gonadal suppression on the regulation of parathyroid hormone and 1,25-dihydroxyvitamin D secretion in women.
Finkelstein JS; Schoenfeld DA
J Clin Endocrinol Metab; 1999 Jun; 84(6):2151-6. PubMed ID: 10372724
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.
Rosen CJ; Chesnut CH; Mallinak NJ
J Clin Endocrinol Metab; 1997 Jun; 82(6):1904-10. PubMed ID: 9177404
[TBL] [Abstract][Full Text] [Related]
9. A new approach for evaluating bone turnover in chronic kidney disease.
Tolouian R; Hernandez GT; Chiang WY; Gupta A
Eur J Intern Med; 2010 Jun; 21(3):230-2. PubMed ID: 20493428
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
Murphy MG; Bach MA; Plotkin D; Bolognese J; Ng J; Krupa D; Cerchio K; Gertz BJ
J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
[TBL] [Abstract][Full Text] [Related]
11. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption.
Ledger GA; Burritt MF; Kao PC; O'Fallon WM; Riggs BL; Khosla S
J Clin Endocrinol Metab; 1995 Nov; 80(11):3304-10. PubMed ID: 7593443
[TBL] [Abstract][Full Text] [Related]
12. Transient Increased Calcium and Calcitriol Requirements After Discontinuation of Human Synthetic Parathyroid Hormone 1-34 (hPTH 1-34) Replacement Therapy in Hypoparathyroidism.
Gafni RI; Guthrie LC; Kelly MH; Brillante BA; Christie CM; Reynolds JC; Yovetich NA; James R; Collins MT
J Bone Miner Res; 2015 Nov; 30(11):2112-8. PubMed ID: 25990370
[TBL] [Abstract][Full Text] [Related]
13. Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.
Smith MR; McGovern FJ; Zietman AL; Fallon MA; Hayden DL; Schoenfeld DA; Kantoff PW; Finkelstein JS
N Engl J Med; 2001 Sep; 345(13):948-55. PubMed ID: 11575286
[TBL] [Abstract][Full Text] [Related]
14. Dietary calcium, sodium, phosphorus, and protein and bone metabolism in elderly Japanese women: a pilot study using the duplicate portion sampling method.
Nakamura K; Hori Y; Nashimoto M; Okuda Y; Miyazaki H; Kasai Y; Yamamoto M
Nutrition; 2004 Apr; 20(4):340-5. PubMed ID: 15043848
[TBL] [Abstract][Full Text] [Related]
15. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
Pantazi H; Papapetrou PD
J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
[TBL] [Abstract][Full Text] [Related]
16. Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study.
Woitge HW; Knothe A; Witte K; Schmidt-Gayk H; Ziegler R; Lemmer B; Seibel MJ
J Bone Miner Res; 2000 Dec; 15(12):2443-50. PubMed ID: 11127208
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
[TBL] [Abstract][Full Text] [Related]
18. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.
Wang C; Eyre DR; Clark R; Kleinberg D; Newman C; Iranmanesh A; Veldhuis J; Dudley RE; Berman N; Davidson T; Barstow TJ; Sinow R; Alexander G; Swerdloff RS
J Clin Endocrinol Metab; 1996 Oct; 81(10):3654-62. PubMed ID: 8855818
[TBL] [Abstract][Full Text] [Related]
19. The effect of gonadotropin-releasing hormone agonist on type I collagen C-telopeptide and N-telopeptide: the predictive value of biochemical markers of bone turnover.
Amama EA; Taga M; Minaguchi H
J Clin Endocrinol Metab; 1998 Feb; 83(2):333-8. PubMed ID: 9467536
[TBL] [Abstract][Full Text] [Related]
20. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
Chen P; Satterwhite JH; Licata AA; Lewiecki EM; Sipos AA; Misurski DM; Wagman RB
J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
